Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-18-020966

Interim CEO bought 130,000 shares at an average $0.40 ($51,731)

From the SEC's structured data for this filing

Trades in this filing

Woods Lori A · Interim CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-11-14 Purchase : show line 1 in the form +125,000 $0.40 $49,738 125,000 D
2018-11-15 Purchase : show line 2 in the form +4,365 $0.40 $1,742 129,365 D
2018-11-15 Purchase : show line 3 in the form +635 $0.40 $252 130,000 D
Open-market purchases · 130,000 sh · avg $0.40 · $51,731
Loading xslF345X03/rdgdoc.xml…